drugset / Trial / NCT01847092
A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine if the study drug is safe, tolerable and active in reducing albuminuria in patients with Chronic Kidney Disease with Type 2 Diabetes.
Timeline
- Start
- 2013-05
- Primary completion
- 2015-03
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tenapanor | Small molecule | 5 mg | Oral |
| Comparator | Tenapanor | Small molecule | 15 mg | Oral |
| Comparator | Tenapanor | Small molecule | 30 mg | Oral |
| Comparator | Tenapanor | Small molecule | 60 mg | Oral |